DLK1 and neoplasm: Limited evidence suggests that tumor cells may inhibit the activation of PPARγ and C/EBPα in adipocytes through the activation of Wnt pathway, and up regulate preadipocyte factor 1, induce its Reprogramming to fibroblasts, and promote tumor development.